Alpha-blockade: monotherapy for hypertension and benign prostatic hyperplasia

By Kaplan S.A.   Kaplan N.M.  

Urology, Vol. 48, Iss. 4, 1996-10 ,pp. : 541-550

Elsevier

Access to resources Recommend Favorite

Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia

By Lin V.K.   Benaim E.A.   McConnell J.D.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 170-175

Elsevier

Access to resources Recommend Favorite

Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months

By Djavan B.   Seitz C.   Roehrborn C.G.   Remzi M.   Fakhari M.   Waldert M.   Basharkhah A.   Planz B.   Harik M.   Marberger M.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 66-70

Elsevier

Access to resources Recommend Favorite

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia

By Baldwin K.C.   Ginsberg P.C.   Roehrborn C.G.   Harkaway R.C.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

By Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 251-259

Elsevier

Access to resources Recommend Favorite